Prospects for Stem Cell-Based Regenerative Therapies in India

  • Boopalan D
  • Pandian R
  • Kesavan G
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Stem cells offer a promising therapeutic strategy to not only treat several incurable diseases but also regenerate damaged tissues. The current global boom in the field of stem cell and regenerative therapies had led to India becoming a global hotspot for stem cell-based therapies. In this review, we assess the current status of stem cell therapy trials in India and show that the bone marrow-derived stem cells, like mesenchymal stem/stromal cells (MSCs), are predominantly used. Phase 1 and 2 clinical trials have also used MSCs to alleviate symptoms of severe novel coronavirus infections. Recent breakthroughs in gene editing technologies, combined with stem cell therapy, can be effectively harnessed to devise large-scale and affordable treatments for haematological diseases that are highly prevalent in India, like beta-thalassemia and sickle cell diseases. Innovations in stem cell therapy in India can make treatments more affordable to address the needs of in-country patients.

Cite

CITATION STYLE

APA

Boopalan, D., Pandian, R., & Kesavan, G. (2021). Prospects for Stem Cell-Based Regenerative Therapies in India. StemJournal, 3(1), 11–21. https://doi.org/10.3233/stj-210002

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free